pharmaphorum
JANUARY 13, 2022
The report from Berkeley Research Group (BRG) – which was funded by the pharma industry trade group PhRMA – reveals a steady decrease in the proportion received by drugmakers from around 67% in 2013 to 49.5%
RX Note
MARCH 24, 2024
Patient Medicine Information under generic medicine info Useful in medication counselling Latest medical news and special reports Product Highlights and Drug Updates where you can learn some newly registered drugs at Malaysia Pill Identifier Continuing Medical Education Disease and condition reference Mobile Application In 2013, MIMS recognized the (..)
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Express Pharma
JUNE 12, 2024
While innovation and availability of medicines is essential, to ensure uniform access to vital life-saving drugs for all individuals irrespective of their socio-economic status, taking a cue from the judgement of the Supreme Court of India in the case of Novartis AG v. Hoffmann-LA Roche and Ors. Vs. Cipla (5). ILR(2009)Supp. (2)Delhi
Express Pharma
JUNE 21, 2024
While innovation and availability of medicines is essential, to ensure uniform access to vital life-saving drugs for all individuals irrespective of their socio-economic status, taking a cue from the judgement of the Supreme Court of India in the case of Novartis AG v. Hoffmann-LA Roche and Ors. Vs. Cipla5. ILR(2009)Supp.(2)Delhi
Express Pharma
NOVEMBER 1, 2024
The FDA’s 505(b)(2) pathway and the European Medicines Agency’s (EMA) Hybrid Pathway offer routes for drug developers to rely on previously submitted clinical data, cutting down approval times significantly. As the world’s largest manufacturer of generic medicines, India has vast potential to utilise repurposed drugs.
Expert insights. Personalized for you.
111 
Let's personalize your content